Responsiveness in rheumatoid arthritis. a report from the OMERACT 11 ultrasound workshop

Annamaria Iagnocco1, Esperanza Naredo, Richard Wakefield

  • 1From the Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Rheumatology Department, Hospital General Universitario Gregorio Marañón and Universidad Complutense, Madrid, Spain; University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, MC Groep Hospitals, Lelystad, The Netherlands; Hospital Universitario Severo Ochoa, Madrid, Spain; Rheumatology Unit, Cavale Blanche Hospital, Brest, France; University of Erlangen-Nuremberg, Department of Internal Medicine 3, Erlangen; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Charitéplatz, Berlin, Germany; Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Université Pierre et Marie Curie, La Pitié Salpêtriere Hospital, APHP, Paris, France; University of Florida College of Medicine, Jacksonville, Florida, USA; Division of Rheumatology, CHU Pitié-Salpêtrière, Paris, France; Instituto Poal, Barcelona, Spain; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Department of Epidemiology and Biostatistics, Université Paris Ouest-Versailles-Saint Quentin en Yvelines, Hôpital Ambroise Paré, APHP, Boulogne-Billancourt, France; Istanbul Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey; National Institute of Rheumatology and Physiotherapy, Budapest, Hungary; Clinica Reumatologica, Università Politecnica delle Marche, Jesi (Ancona), Italy; Division of Rheumatology, Medical University of Vienna, Vienna, Austria; Biomedical Research, Instituto Nacional de Rehabilitación, Mexico City, Mexico; University of Ottawa, Children's Hospital of Eastern Ontario, Ottawa, Canada; Division of Rheumatology IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy; Department of Pediatric Rheumatology, Center for Rheumatic Diseases, Bad

The Journal of Rheumatology
|November 19, 2013
PubMed
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
548
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.7K